
Backed by Niagen Bioscience's 25 years of innovation and research.
About Tru Niagen
Developed by Niagen Bioscience (formerly ChromaDex), a pioneer in NAD+ and healthy-ageing research, Tru Niagen® is the number one NAD+ boosting supplement in the United States.
Helping people around the world transform the way they age, Tru Niagen is proven to increase NAD+ levels. Featuring Niagen®, patented nicotinamide riboside (NR), the most efficient and superior-quality NAD+ precursor available on the market.
We set the gold standard in scientific rigor, quality, and transparency. Backed by two Nobel Prize winners, 35+ human clinical studies, and 400+ published scientific studies, and has been accepted by the world’s most rigorous regulatory bodies.
We want to get the most out of every moment. Our purpose is to invigorate life, even through challenging times.

Setting the gold standard in the supplement industry since 1999.
Niagen Bioscience, formerly ChromaDex, represents 25 years of world-leading scientific innovation and excellence. Tru Niagen is backed by Nobel prize-winning scientists, 35+ published peer-reviewed human clinical studies and 400+ published studies.
Backed by world-leading scientists
Tru Niagen, powered by Niagen Bioscience, leverages 25 years of scientific excellence. Our foundation is solidified by an esteemed scientific advisory board, including Nobel Prize laureates Sir John Walker (Cambridge) and Dr. Roger Kornberg (Stanford).Our Chief Scientific Advisor is Dr. Charles Brenner, a world-leading pioneer in NAD+ research, who discovered the NAD-boosting potential of our star ingredient, NR. Our commitment to cutting-edge research and innovation drives our mission to enhance health and longevity.

Our dedication to scientific research
We value and encourage strong scientific rigor and evidence behind our claims. We have a dedicated state-of-the-art research and development facility in Longmont, Colorado. Our science is global with more than 275+ research collaborations through the ChromaDex External Research Program (CERP), a division of Niagen Bioscience.